Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. S-1MEF Other S-1MEF
  8. CERT Other Certification
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. 8-A12B Other Registration of Securities
  12. S-1/A Offering Registration Statement
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1/A Offering Registration Statement
  19. S-1 Offering Registration Statement
  20. UPLOAD Other SEC-generated Letter

Page 20 of 21 · 403 filings